A RT I C L E mice lacking EP3 receptors for prostaglandin E2. Am. J. Physiol. 275:F955–F961. 47. Nguyen, M., T. Camenish, J.N. Snouweert, E. Hicks, T.M. Coffman, P.A.W. Anderson, N.N. Malouf, and B.H. Koller. 1997. The prosta- glandin receptor EP4 triggers remodeling of the cardiovascular system at birth. Nature. 390:78–81. 48. Sugimoto, Y., and S. Narumyia. 2007. Prostaglandin E receptors. J. Biol. Chem. 282:11613–11617. 49. Fujino, H., K.A. West, and J.W. Regan. 2002. Phosphorylation of gly- cogen synthase kinase-3 and stimulation of T-cell factor signaling fol- lowing activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J. Biol. Chem. 277:2614–2619. 50. Zha, J., H. Harada, E. Yang, J. Jockel, and S.J. Korsmeyer. 1996. Serine phosphorylation of death agonist BAD in response to survival factor re- sults in binding to 14-3-3 not BCL-X(L). Cell. 87:619–628. 51. Datta, S.R., A. Katsov, L. Hu, A. Petros, S.W. Fesik, M.B. Yaffe, and M.E. Greenbert. 2000. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol. Cell. 6:41–51. 52. Fujino, H., W. Xu, and J.W. Regan. 2003. Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and ex- tracellular signal-regulated kinases. J. Biol. Chem. 278:12151–12156. 53. Simpson, C.S., and B.J. Morris. 1995. Induction of c-fos and zif/268 gene expression in rat striatal neurons, following stimulation of D1- like dopamin receptors, involves protein kinase A and protein kinase C. Neuroscience. 68:97–106. 54. Vlahos, C.J., W.F. Matter, R.Y. Hui, and R.F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl- 4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241–5248. 55. Chiang, N., I.M. Fierro, K. Gronert, and C.N. Serhan. 2000. Activation of lipoxin A4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 191:1197–1208. 56. Ariel, A., and C.N. Serhan. 2007. Resolvins and protectins in the ter- mination program of acute inflammation. Trends Immunol. 28:176–183. 57. Houchen, C.W., M.A. Sturmoski, S. Anant, R.M. Breyer, and W. Stenson. 2002. Prosurvival and antiapoptotic effects of PGE2 in radia- tion injury are mediated by EP2 receptor in intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 284:G490–G498. 58. George, R.J., M.A. Sturmoski, S. Anant, and C.W. Houchen. 2007. EP4 mediates PGE2 dependent cell survival through the PI3 kinase/ AKT pathway. Prostaglandins Other Lipid Mediat. 83:112–120. 59. Chen, W., Y.L. Yu, S.F. Lee, Y.J. Chiang, J.R. Chao, J.H. Huang, C.H. Chiong, J. Huang, M.Z. Lai, J.F. Yang-Yen, and J.J. Yen. 2001. CREB is one component of the binding complex of the Ces-2/E2A- HLF binding element and is an integral part of the interleukin-3 survival signal. Mol. Cell. Biol. 21:4636–4646. 60. Medzhitov, R., and C.A. Janeway Jr. 1997. Innate immunity: the vir- tues of a nonclonal system of recognition. Cell. 91:295–298. 61. Fadok, V.A., D.L. Bratton, and P.M. Henson. 2001. Phagocyte recep- tors for apoptotic cells: recognition, uptake, and consequences. J. Clin. Invest. 108:957–962. 62. Lu, Y., S. Hong, E. Tjonahen, and C.N. Serhan. 2005. Mediator- lipidomics: databases and search algorithms for PUFA-derived mediators. J. Lipid Res. 46:790–802. 63. Elbashir, S.M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA in- terference in cultured mammalian cells. Nature. 411:494–496. JEM VOL. 205, November 24, 2008 2801